Results 141 to 150 of about 6,554,877 (306)

Tissue engineering. Part C: Methods.

open access: yes
Ten dele voortzetting van: Tissue engineering [ISSN 1076 ...
Tissue engineering and regenerative medicine international society
core  

Tissue-protective cytokines

open access: yes, 2013
While many cytokines are known for their inflammatory action, there is a growing interest in the tissue-protective effects of some cytokines. The prototypic tissue-protective cytokine is EPO.
Pietro Ghezzi (4462387)   +1 more
core  

[Tissue Sketches 243]

open access: yes, 2005
Woman (Mary) sitting and playing the guitar, baby Jesus lying in manger. Letter studies in uppeer and lower case of the letters "D", "H", and "R".
Father Edward Catich
core   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

TISSUE AND BONE TISSUE AND THEIR DEVELOPMENT

open access: yes
This article analyzes the structure, development, and biological significance of cartilage and bone, which are important types of connective tissue in the human body. The hyaline, elastic, and fibrous types of cartilage, their cellular composition (chondrocytes, chondroblasts), and the properties of the intermediate substance are discussed. The article
Saidov, Shoxurullo   +2 more
openaire   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Tissue Mast Cells and Tissue Amines [PDF]

open access: yesJournal of Pharmacy and Pharmacology, 1959
openaire   +2 more sources

Breast Cancer Tissue Bank Blood Samples

open access: yes
This BCTB subcollection consists of blood samples taken from breast cancer patients and others. It is further broken down into a number of blood components.

core  

Home - About - Disclaimer - Privacy